Cargando…

Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction

BACKGROUND: Leukodystrophies are devastating diseases characterized by dys- and hypo-myelination. While there are a number of histological and imaging studies of these disorders, there are limited biochemical data available. We undertook targeted lipidomic analyses of Pelizaeus-Merzbacher disease (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood, Paul L, Smith, Tara, Pelzer, Lindsay, Goodenowe, Dayan B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141545/ https://www.ncbi.nlm.nih.gov/pubmed/21682894 http://dx.doi.org/10.1186/1476-511X-10-102

Ejemplares similares

In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor
por: Wood, Paul L, et al.
Publicado: (2011)

Pelizaeus-Merzbacher disease in siblings
por: Mittal, Amit, et al.
Publicado: (2010)

Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease
por: Elitt, Matthew S., et al.
Publicado: (2020)

Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
por: Wood, Paul L, et al.
Publicado: (2011)

Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease
por: Velasco Parra, Harvy Mauricio, et al.
Publicado: (2018)

Optical genome mapping in an atypical Pelizaeus-Merzbacher prenatal challenge
por: Rogac, Mihael, et al.
Publicado: (2023)

Genotype–phenotype correlation and natural history analyses in a Chinese cohort with pelizaeus–merzbacher disease
por: Duan, Ruoyu, et al.
Publicado: (2022)

A genetically proven case of Pelizaeus-Merzbacher disease: Clinicoradiological clues
por: Saini, Lokesh, et al.
Publicado: (2016)

Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus‐Merzbacher disease
por: Ruiz, Montserrat, et al.
Publicado: (2017)

Cellular Pathology of Pelizaeus-Merzbacher Disease Involving Chaperones Associated with Endoplasmic Reticulum Stress
por: Inoue, Ken
Publicado: (2017)

Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
por: Senanayake, Vijitha, et al.
Publicado: (2019)

Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease
por: Edgar, Julia M, et al.
Publicado: (2010)

Pelizaeus–Merzbacher Disease: the First Genetically Approved Case Report from Iran
por: Ashrafi, Mahmoud-Reza, et al.
Publicado: (2011)

Potential for Cell-Mediated Immune Responses in Mouse Models of Pelizaeus-Merzbacher Disease
por: Southwood, Cherie M., et al.
Publicado: (2013)

New Mutation of Pelizaeus-Merzbacher-Like Disease; A Report from Iran
por: Karimzadeh, Parvaneh, et al.
Publicado: (2014)

Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
por: Stumpf, Sina K., et al.
Publicado: (2019)

Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease
por: Epplen, Dirk B, et al.
Publicado: (2015)

Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease
por: Gruenenfelder, Fredrik I, et al.
Publicado: (2020)

Correction to: Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
por: Stumpf, Sina K., et al.
Publicado: (2019)

Magnetic Resonance Imaging and Spectroscopy Analysis in a Pelizaeus–Merzbacher Disease Rat Model
por: Ishikawa, Maho, et al.
Publicado: (2022)

Missense mutation of MAL causes a rare leukodystrophy similar to Pelizaeus-Merzbacher disease
por: Elpidorou, Marilena, et al.
Publicado: (2022)

Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease
por: Gow, Alexander, et al.
Publicado: (1998)

Unusual Presentation of Pelizaeus-Merzbacher Disease: Female Patient with Deletion of the Proteolipid Protein 1 Gene
por: Brender, Teva, et al.
Publicado: (2015)

Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1
por: Kouga, Takeshi, et al.
Publicado: (2019)

Novel Mutations in NPC1 are Associated with Pelizaeus-Merzbacher-Like Disease: A Case Report
por: Fu, Hongling, et al.
Publicado: (2021)

Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study
por: Goodenowe, Dayan B., et al.
Publicado: (2019)

Familial Case of Pelizaeus-Merzbacher Disorder Detected by Oligoarray Comparative Genomic Hybridization: Genotype-to-Phenotype Diagnosis
por: Najafi, Kimia, et al.
Publicado: (2017)

Anesthetic challenges and successful management of a child with Pelizaeus–Merzbacher disease using general and caudal anesthesia
por: Kapoor, Ravish, et al.
Publicado: (2018)

Pelizaeus-Merzbacher Disease in a 4-Year-Old Female Child: “A Rare Case Report”
por: Gagan, Devesh, et al.
Publicado: (2023)

The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series
por: Trepanier, Angela M., et al.
Publicado: (2023)

Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons
por: Goodenowe, Dayan B., et al.
Publicado: (2022)

Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease
por: Wood, Paul L, et al.
Publicado: (2011)

Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
por: Goodenowe, Dayan B., et al.
Publicado: (2022)

Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study
por: Mankidy, Rishikesh, et al.
Publicado: (2010)

Magnetic resonance imaging and spectroscopic analysis in 5 cases of Pelizaeus-Merzbacher disease: metabolic abnormalities as diagnostic tools
por: Lee, Eun, et al.
Publicado: (2012)

Pelizaeus-Merzbacher disease can be a differential diagnosis in males presenting with severe neonatal respiratory distress and hypotonia
por: Ueda, Ayako, et al.
Publicado: (2018)

Deep intronic deletion in intron 3 of PLP1 is associated with a severe phenotype of Pelizaeus-Merzbacher disease
por: Yamamoto-Shimojima, Keiko, et al.
Publicado: (2021)

Prenatal diagnosis of PLP1 duplication by single nucleotide polymorphism array in a family with Pelizaeus-Merzbacher disease
por: Xue, Huili, et al.
Publicado: (2021)

Altered high-energy phosphate and membrane metabolism in Pelizaeus–Merzbacher disease using phosphorus magnetic resonance spectroscopy
por: Laukka, Jeremy J, et al.
Publicado: (2022)

Epidural Anesthesia and Continuous Epidural Analgesia in a Pediatric Patient With Pelizaeus-Merzbacher Disease: A Case Report
por: Maruta, Toyoaki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ptjgj9drh8q81dt37m09ilghue